News & Analysis on Clinical Trial Services & Contract Research And Development
Biotechnology firm Apollo claims to have achieved mission impossible in the oral delivery of insulin by successfully lowering blood glucose levels in diabetic rats using its proprietary oral delivery technology.
Researchers believe that a little-known antibiotic could well prove effective against cancer, showing promise because it has not shown toxic side effects, which continue to blight current anti-cancer agents.
PainCeptor Pharma has announced it has been awarded a series of patents for its drug development programs that focus on pain management whilst avoiding the many detrimental side effects associated with current pain drugs.
Clinical research organisations (CROs) should be enlisted to run Phase I oncology drug trials in order to improve efficiencies, delegates heard at Pabord 2006 in London.
The European Commission continues to be accused by European industry of pushing 'green policies' that are stifling progress and global competitiveness - the controversial REACH chemicals legislation remains a sore point.
Mobious Genomics has announced a prototype version of a new immunoassay that identified a low concentration bacterial sample within 40 seconds, vastly improving on the six - forty eight hours it currently takes to identify the same sample.
Following numerous manufacturing failures, Discovery Laboratories believes it has resolved the stability issues that have plagued Surfaxin, its experimental respiratory treatment for infants, and is now seeking a meeting with the US Food and Drug...
Indian biopharmaceutical company Wockhardt has signed a deal with Maharashtra Industrial Development Corporation (MIDC) to establish a special economic zone (SEZ) in Aurangabad, India, in order to expand its manufacturing capabilities.